Archer Investment Corp - QUALIGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Archer Investment Corp ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$43,000
-52.7%
1600.0%0.00%
Q2 2022$91,000
-14.2%
1600.0%0.00%
Q1 2022$106,000
-38.0%
1600.0%0.00%
Q4 2021$171,000
-17.8%
1600.0%0.00%
Q3 2021$208,000
-34.6%
1600.0%0.00%
Q2 2021$318,000
-26.4%
1600.0%0.00%
Q1 2021$432,000
-10.4%
1600.0%0.00%
Q4 2020$482,000
-39.1%
1600.0%0.00%
Q3 2020$792,000
+24.7%
1600.0%0.00%
Q2 2020$635,0001600.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$104,0000.08%
PERKINS CAPITAL MANAGEMENT INC 51,178$67,0000.04%
HATTON CONSULTING, INC. 27,195$35,0000.03%
GSA CAPITAL PARTNERS LLP 78,687$102,0000.01%
CRA Financial Services, LLC 19,957$26,0000.01%
Virtu Financial LLC 25,507$33,0000.00%
WEDBUSH SECURITIES INC 32,228$42,0000.00%
TWO SIGMA SECURITIES, LLC 15,347$20,0000.00%
UBS Group AG 13,118$17,0000.00%
US BANCORP \DE\ 9,047$12,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders